Investors

Welcome to our investor resources section, where you can access comprehensive information about our financial performance and strategic initiatives. Explore our latest reports, presentations, and updates to stay informed about Vitrafy’s growth and opportunities.

ASX Announcements

DateTitle
15 January 2026IMV Strategic Commercial Agreement Investor BriefingView Now
15 January 2026IMV Strategic Partnership Investor PresentationView Now
15 January 2026Vitrafy Enters Strategic Commercial Agreement with IMVView Now
15 December 2025Change of Director's Interest NoticeView Now
15 December 2025Notification regarding unquoted securities - VFYView Now
21 November 2025Change of Director's Interest NoticeView Now
21 November 2025Notification of cessation of securities - VFYView Now
21 November 2025Final Director's Interest NoticesView Now
21 November 2025Application for quotation of securities - VFYView Now
20 November 2025Results of 2025 Annual General MeetingView Now
20 November 2025Results of 2025 Annual General MeetingView Now
20 November 20252025 Annual General Meeting Chair Address & PresentationView Now
19 November 2025Bell Potter Healthcare Conference PresentationView Now
7 November 2025Release of Securities from Mandatory EscrowView Now
23 October 2025Quarterly Investor Briefing PresentationView Now
22 October 2025Q1 FY26 Quarterly Activities Report and Appendix 4CView Now
20 October 2025Vitrafy Q1 FY26 Investor BriefingView Now
17 October 20252025 Notice of Annual General MeetingView Now
16 October 2025Initial Director's Interest NoticeView Now
16 October 2025Board Renewal View Now
6 October 2025Managing Director and CEO Remuneration UpdateView Now
2 October 2025ASX Waiver Request GrantedView Now
1 September 2025Change of Director's Interest NoticeView Now
5 August 2025FY25 Full Year Results Presentation - AmendedView Now
5 August 2025FY25 Corporate Governance StatementView Now
5 August 2025FY25 Appendix 4GView Now
5 August 2025FY25 Full Year Results PresentationView Now
5 August 2025FY25 Appendix 4E and Annual ReportView Now
5 August 2025Leadership Transition at VitrafyView Now
31 July 2025Expiry of Voluntary Escrow RestrictionsView Now
29 July 2025Appendix 4C, FY25 Annual Results and Investor Call ScheduleView Now
25 Jun 2025Notification of cessation of securities - VFYView Now
30 May 2025Change of AddressView Now
15 May 2025Application for quotation of securities - VFYView Now
02 May 2025Vitrafy Q3 FY25 Investor PresentationView Now
02 May 2025Release of Securities from Mandatory EscrowView Now
29 Apr 2025Vitrafy Life Sciences Quarterly Activities Report & Appendix 4C - Quarter 3, Financial Year 2025View Now
28 Apr 2025 Vitrafy Q3 FY25 Investor BriefingView Now
16 Apr 2025USAISR successful Phase 1 Blood Platelet studyView Now
15 Apr 2025Notification regarding unquoted securities - VFYView Now
08 Apr 2025Application for quotation of securities - VFYView Now
27 Mar 2025Release of Securities from Mandatory EscrowView Now
20 Mar 2025NWR Virtual Healthcare Conference PresentationView Now
19 Mar 2025Vitrafy to present at NWR Virtual Healthcare ConferenceView Now
19 Mar 2025Change of Director's Interest NoticeView Now
18 Mar 2025Vitrafy Awarded Industry Growth Program GrantView Now
28 Feb 2025Notification of cessation of securities - VFYView Now
21 Feb 2025Application for quotation of securities - VFYView Now
10 Feb 2025Application for quotation of securities - VFYView Now
06 Feb 2025FY25 Half Year Results PresentationView Now
06 Feb 2025FY25 Appendix 4D and Half Year ReportView Now
04 Feb 2025Vitrafy Half Year FY25 Investor BriefingView Now
31 Jan 2025Release of Securities from Mandatory EscrowView Now
31 Jan 2025Q2 FY25 Quarterly Activities Report and Appendix 4CView Now
12 Dec 2024Revised Securities Trading PolicyView Now
10 Dec 2024Change of Director's Interest NoticeView Now
27 Nov 2024Becoming a substantial holder from RYDView Now
26 Nov 2024Initial Director's Interest NoticeView Now
26 Nov 2024Initial Director's Interest NoticeView Now
26 Nov 2024Initial Director's Interest NoticeView Now
26 Nov 2024Initial Director's Interest NoticeView Now
26 Nov 2024Initial Director's Interest NoticeView Now
22 Nov 2024Pre-Quotation Disclosure StatementView Now
22 Nov 2024Top 20 HoldersView Now
22 Nov 2024Distribution ScheduleView Now
22 Nov 2024Securities Trading PolicyView Now
22 Nov 2024Equity Incentive Plan RulesView Now
22 Nov 2024Annual Report - 30 June 2024View Now
22 Nov 2024Annual Report - 30 June 2023View Now
22 Nov 2024ConstitutionView Now
22 Nov 2024Replacement ProspectusView Now
22 Nov 2024Information Form and ChecklistView Now
22 Nov 2024Appendix 1AView Now
22 Nov 2024ASX Market Announcement - Admission and QuotationView Now

Reports & Presentations

Click here

Corporate Governance

Corporate
Reports

Corporate Charters

Corporate Policies

Vitrafy FY25 Corporate Governance Statement

Download PDF

Vitrafy Board Charter

Download PDF

Audit and Risk Committee Charter

Download PDF

Remuneration & Nomination Committee Charter

Download PDF

Anti Bribery and Corruption Policy

View Policy

Code of Conduct

View Policy

Continuous Disclosure Policy

View Policy

Diversity Policy

View Policy

Securities Trading Policy

View Policy

Statement of Values

View Policy

Whistleblower Policy

View Policy

Get in Contact

Registered Address

Vitrafy Life Sciences Limited

Level 11, 385 Bourke Street, Melbourne, VIC 3205, Australia

Email: [email protected]

Share Registry

Xcend Pty Ltd

Level 2, 477 Pitt Street, Haymarket, NSW 2000 Australia

Email: [email protected]

Stay Tuned